Corcept Therapeutics's chart data is dated 2026-10-08. There is no active technical signal. There are 10 published signal records.
Corcept Therapeutics last closed at $118.54 (-0.89%) on 2026-10-08. Listed on Nasdaq. Trailing 12 months PER is 255.6×. Its overall grade ranks 101 of 738 stocks in Healthcare.
About this company
Corcept Therapeutics last closed at $118.54 (-0.89%) on 2026-10-08. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall A · 101/738
Valuation grade F
Related stocks
- AstraZenecaCompetitor
쿠싱증후군 등 내분비·희귀질환 치료제 경쟁 가능성이 있는 글로벌 제약사
- PfizerCompetitor
중추신경계·내분비·희귀질환 영역에서 경쟁 가능한 대형 제약사
- NovartisCompetitor
희귀질환·내분비 치료제 포트폴리오를 가진 글로벌 제약사
ETFs holding this stock
Invesco S&P SmallCap Health Care ETF · F/m Emerald Special Situations ETF · Invesco Dynamic Pharmaceuticals ETF
Details →About Corcept Therapeutics
- What technical signals does Corcept Therapeutics (CORT) have?
- Corcept Therapeutics current technical signals: no active technical signal.
- Is Corcept Therapeutics a cup-and-handle pattern?
- No. Corcept Therapeutics has no valid Cup signal right now.
- What published figures are available for Corcept Therapeutics?
- Market cap: $12.47B. Trailing 12 months PER: 255.6×. Latest quarter PBR: 19.88×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-09 dataset
Turn what you saw on this name into a strategy
Ask Q about Corcept Therapeutics, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.